DK542279A - Farmaceutisk praeparat som indeholder et hjertestyrkende glykosid med en polymer belaegning - Google Patents

Farmaceutisk praeparat som indeholder et hjertestyrkende glykosid med en polymer belaegning

Info

Publication number
DK542279A
DK542279A DK542279A DK542279A DK542279A DK 542279 A DK542279 A DK 542279A DK 542279 A DK542279 A DK 542279A DK 542279 A DK542279 A DK 542279A DK 542279 A DK542279 A DK 542279A
Authority
DK
Denmark
Prior art keywords
glycoside
pharmaceutical preparation
health
controlling
polymer coating
Prior art date
Application number
DK542279A
Other languages
English (en)
Inventor
C H Appelgren
C B Bogentoft
J A Sjoegren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DK542279A publication Critical patent/DK542279A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
DK542279A 1978-12-22 1979-12-19 Farmaceutisk praeparat som indeholder et hjertestyrkende glykosid med en polymer belaegning DK542279A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7813246A SE7813246L (sv) 1978-12-22 1978-12-22 Fast farmaceutisk beredning innehallande kroppar med flera ytskikt

Publications (1)

Publication Number Publication Date
DK542279A true DK542279A (da) 1980-06-23

Family

ID=20336689

Family Applications (1)

Application Number Title Priority Date Filing Date
DK542279A DK542279A (da) 1978-12-22 1979-12-19 Farmaceutisk praeparat som indeholder et hjertestyrkende glykosid med en polymer belaegning

Country Status (20)

Country Link
US (1) US4263273A (da)
EP (1) EP0013262B1 (da)
JP (1) JPS5587716A (da)
AT (1) ATE4370T1 (da)
AU (1) AU531280B2 (da)
BE (1) BE880797A (da)
CA (1) CA1130211A (da)
CH (1) CH641357A5 (da)
DE (1) DE2966036D1 (da)
DK (1) DK542279A (da)
ES (1) ES8101887A1 (da)
FI (1) FI794007A (da)
GR (1) GR69819B (da)
IE (1) IE48891B1 (da)
LU (1) LU82026A1 (da)
NO (1) NO152726C (da)
NZ (1) NZ192441A (da)
PT (1) PT70619A (da)
SE (1) SE7813246L (da)
ZA (1) ZA796684B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
EP0064485B1 (en) * 1981-04-27 1985-07-24 Aktiebolaget Hässle New pharmaceutical preparation
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
IE56459B1 (en) * 1983-12-21 1991-08-14 Elan Corp Ltd Controlled absorption pharmaceutical formulation
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
JPH0759499B2 (ja) 1984-02-10 1995-06-28 ベンツォン ファーマ エイ／エス 拡散被覆された複合単位服用剤
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
US4656831A (en) * 1985-05-14 1987-04-14 Chamberlain Manufacturing Corporation Apparatus and method of recovering water from engine exhaust gases
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US5601835A (en) * 1987-04-29 1997-02-11 Massachusetts Institute Of Technology Polymeric device for controlled drug delivery to the CNS
US4883666A (en) * 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US5912017A (en) * 1987-05-01 1999-06-15 Massachusetts Institute Of Technology Multiwall polymeric microspheres
US5985354A (en) * 1995-06-07 1999-11-16 Brown University Research Foundation Preparation of multiwall polymeric microcapsules from hydrophilic polymers
JPH0774151B2 (ja) * 1987-10-12 1995-08-09 三井東圧化学株式会社 薬物の好ましくない官能的性質を隠蔽した散剤の製造方法
JPH01165520A (ja) * 1987-12-23 1989-06-29 Shin Etsu Chem Co Ltd 持続性製剤およびその製造方法
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
FR2663222A1 (fr) * 1990-06-13 1991-12-20 Medgenix Group Sa Microcapsule de liquide huileux.
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5167964A (en) * 1992-02-14 1992-12-01 Warner-Lambert Company Semi-enteric drug delivery systems and methods for preparing same
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2455790A (en) * 1945-06-09 1948-12-07 Eastman Kodak Co Enteric coatings
CH283585A (de) * 1950-03-15 1952-06-15 Hoffmann La Roche Zur Herstellung von Tablettenüberzügen geeignetes Gemisch.
US2698822A (en) * 1951-04-28 1955-01-04 Fougera & Co Inc E Cardiac glycoside buccal composition
US2881085A (en) * 1953-11-09 1959-04-07 Abbott Lab Thin film coating for tablets and the like
US2853420A (en) * 1956-01-25 1958-09-23 Lowey Hans Ethyl cellulose coatings for shaped medicinal preparations
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
NL251030A (da) * 1959-04-30
NL122039C (da) * 1960-10-20
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3325365A (en) * 1963-04-02 1967-06-13 Ciba Geigy Corp Enteric composition for tablet compression coating
NL297631A (da) * 1963-06-03
US3400185A (en) * 1965-04-08 1968-09-03 Bristol Myers Co Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
IL42166A (en) * 1973-05-02 1976-01-30 Res Prod Rehovot Ltd Drug releasing preparation
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US3965255A (en) * 1974-05-01 1976-06-22 E. E. Eljim Ecology Ltd. Controlled drug releasing preparations
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
SE418247B (sv) 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
US4147768A (en) * 1976-09-13 1979-04-03 Interx Research Corporation Enteric coated digoxin and therapeutic use thereof

Also Published As

Publication number Publication date
ZA796684B (en) 1980-11-26
BE880797A (fr) 1980-06-23
LU82026A1 (fr) 1980-07-21
IE792454L (en) 1980-06-22
US4263273A (en) 1981-04-21
IE48891B1 (en) 1985-06-12
CA1130211A (en) 1982-08-24
NO794252L (no) 1980-06-24
DE2966036D1 (en) 1983-09-08
EP0013262A3 (en) 1981-05-27
SE7813246L (sv) 1980-06-23
ES487181A0 (es) 1980-12-16
NO152726B (no) 1985-08-05
NZ192441A (en) 1984-05-31
AU531280B2 (en) 1983-08-18
ES8101887A1 (es) 1980-12-16
CH641357A5 (de) 1984-02-29
JPS5587716A (en) 1980-07-02
FI794007A (fi) 1980-06-23
PT70619A (en) 1980-01-01
AU5396379A (en) 1980-06-26
NO152726C (no) 1985-11-13
GR69819B (da) 1982-07-13
ATE4370T1 (de) 1983-08-15
EP0013262A2 (en) 1980-07-09
EP0013262B1 (en) 1983-08-03

Similar Documents

Publication Publication Date Title
DK542279A (da) Farmaceutisk praeparat som indeholder et hjertestyrkende glykosid med en polymer belaegning
ATE101340T1 (de) Neue arzneimittelformulierung sowie verfahren zu deren herstellung.
ES2019275B3 (es) Metodo para la produccion de una forma de administracion y de dosificacion para farmacos reactivos u otros principios activos.
IS3644A7 (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
ES442579A1 (es) Procedimiento para preparar formulaciones de 1-dopa en uni- dades de dosificacion con revestimiento enterico-efervescen-te.
ZA975827B (en) Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production.
CA982478A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
BE848310A (fr) Acides di(phenoxy-2 alcane carboxyliques), leur procede de preparation et leur utilisation comme medicaments
BE794414A (fr) Nouveaux amino-alcools, leur preparation et leur application comme medicament
NL164472B (nl) Werkwijze ter bereiding van een voor orale toediening geschikt farmaceutisch preparaat dat geschikt is voor de behandeling van oesofagitis, alsmede onder toe- passing daarvan verkregen voorwerp.
BE786713A (fr) Nouveaux amino-alcools, leur preparation et leur application comme medicaments
FI873407A0 (fi) Menetelmä pitkävaikutteisen moniraetabletin valmistamiseksi
AU465951B2 (en) Pyrimidin-6yl acethydroxamic acids, their method of preparation and their therapeutic application
BE792078A (fr) Nouveaux derives de l'indazole, leur preparation et leur application comme medicaments
BE787235A (fr) Nouveaux derives du thiophene, leur preparation et leur application comme medicaments
BE780473A (fr) Derives de lumilysergol, leur procede de preparation et leurs applications comme medicaments notamment adrenolytiques
BE861337A (fr) Nouveaux derives imidazoliques leur procede de preparation et leur application comme medicaments
IE780032L (en) Preparation of antidiarrheal agents
BE785389A (fr) Nouveaux amino-alcools, leur preparation et leur application comme medicaments
CA988423A (en) Pharmaceutical preparation for percutaneous treatment of local edemas
RU95112241A (ru) Способ коррекции побочных эффектов химиолучевой терапии
RO92640B1 (ro) Metoda pentru tratamentul keratitelor virotice
BE778252A (fr) Nouveaux derives de l'inden0(1,2-c)-pyridine, leur preparation et leur application comme medicaments
IL38774A0 (en) A pharmaceutical preparation for dermatological administration for the treatment of hyperkeratosis
CA959844A (en) Process for producing non-hypnotic pure 5-allyl-5-(2-hydroxyethyl) barbituric acid, pharmaceutical preparation for therapeutic treatment, and method of carrying out therapeutic treatments

Legal Events

Date Code Title Description
ATS Application withdrawn